KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Adaptive Biotechnologies (ADPT) Debt Ratio (2022 - 2025)

Historic Debt Ratio for Adaptive Biotechnologies (ADPT) over the last 4 years, with Q3 2025 value amounting to 0.27.

  • Adaptive Biotechnologies' Debt Ratio rose 1309.96% to 0.27 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.27, marking a year-over-year increase of 1309.96%. This contributed to the annual value of 0.25 for FY2024, which is 2503.08% up from last year.
  • According to the latest figures from Q3 2025, Adaptive Biotechnologies' Debt Ratio is 0.27, which was up 1309.96% from 0.27 recorded in Q2 2025.
  • Adaptive Biotechnologies' Debt Ratio's 5-year high stood at 0.27 during Q2 2025, with a 5-year trough of 0.15 in Q4 2022.
  • For the 4-year period, Adaptive Biotechnologies' Debt Ratio averaged around 0.22, with its median value being 0.23 (2024).
  • Its Debt Ratio has fluctuated over the past 5 years, first surged by 3504.57% in 2023, then surged by 1309.96% in 2025.
  • Quarter analysis of 4 years shows Adaptive Biotechnologies' Debt Ratio stood at 0.15 in 2022, then surged by 35.05% to 0.2 in 2023, then rose by 25.03% to 0.25 in 2024, then rose by 8.75% to 0.27 in 2025.
  • Its Debt Ratio stands at 0.27 for Q3 2025, versus 0.27 for Q2 2025 and 0.26 for Q1 2025.